Page last updated: 2024-08-17

carbostyril and Bone Demineralization, Pathologic

carbostyril has been researched along with Bone Demineralization, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Delion, M; Durieu, I; Hubert, D; Jacquot, J; Sermet-Gaudelus, I	1

Other Studies

1 other study(ies) available for carbostyril and Bone Demineralization, Pathologic

Article	Year
Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2016, Volume: 15, Issue:6 Topics: Adult; Aminophenols; Bone Demineralization, Pathologic; Bone Density; Cells, Cultured; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Male; Middle Aged; Mutation; Osteoblasts; Quinolones; Statistics as Topic	2016

Article

Year

Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society, 2016, Volume: 15, Issue:6

Topics: Adult; Aminophenols; Bone Demineralization, Pathologic; Bone Density; Cells, Cultured; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Male; Middle Aged; Mutation; Osteoblasts; Quinolones; Statistics as Topic

2016